Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-26

FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for pioglitazone hydrochloride (generic), with Chartwell RX, LLC listed as the sponsor/manufacturer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone hydrochloride (Pioglitazone hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE)